{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:44:43Z","timestamp":1776318283742,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:00:00Z","timestamp":1719100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40256-024-00660-6","type":"journal-article","created":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T14:01:35Z","timestamp":1719151295000},"page":"663-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience"],"prefix":"10.1007","volume":"24","author":[{"given":"Paolo","family":"Severino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Valerio","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Myftari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Labbro Francia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cesti\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Tomarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Ilaria","family":"Birtolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Marek-Iannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Maestrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine Dario","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,23]]},"reference":[{"key":"660_CR1","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","DOI":"10.1093\/eurheartj\/ehab368"},{"issue":"1","key":"660_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ejhf.2754","volume":"25","author":"G Cotter","year":"2023","unstructured":"Cotter G, Davison B, Cohen-Solal A, Freund Y, Mebazaa A. Targeting the \u2018vulnerable\u2019 period\u2014first 3\u20136 months after an acute heart failure admission - the light gets brighter. Eur J Heart Fail. 2023;25(1):30\u20134. https:\/\/doi.org\/10.1002\/ejhf.2754.","journal-title":"Eur J Heart Fail"},{"key":"660_CR3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejhf.822","volume":"19","author":"MA Mamas","year":"2017","unstructured":"Mamas MA, Sperrin M, Watson MC, Coutts A, Wilde K, Burton C, et al. Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland. Eur J Heart Fail. 2017;19:1095\u2013104.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"660_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","volume":"61","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61(4):391\u2013403. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.038.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"660_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/cdt-20-302","volume":"11","author":"RHG Schwinger","year":"2021","unstructured":"Schwinger RHG. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021;11(1):263\u201376. https:\/\/doi.org\/10.21037\/cdt-20-302.","journal-title":"Cardiovasc Diagn Ther."},{"key":"660_CR6","doi-asserted-by":"publisher","unstructured":"Severino P, D'Amato A, Prosperi S, Dei Cas A, Mattioli AV, Cevese A, Novo G, Prat M, Pedrinelli R, Raddino R, Gallina S, Schena F, Poggesi C, Pagliaro P, Mancone M, Fedele F, on Behalf of the Italian National Institute for Cardiovascular Research Inrc. Do the current guidelines for heart failure diagnosis and treatment fit with clinical complexity? J Clin Med. 2022;11(3):857. https:\/\/doi.org\/10.3390\/jcm11030857.","DOI":"10.3390\/jcm11030857"},{"issue":"3","key":"660_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/jcm12031020","volume":"12","author":"P Severino","year":"2023","unstructured":"Severino P, D\u2019Amato A, Prosperi S, Myftari V, Canuti ES, Labbro Francia A, Cesti\u00e8 C, Maestrini V, Lavalle C, Badagliacca R, Mancone M, Vizza CD, Fedele F. Heart failure pharmacological management: gaps and current perspectives. J Clin Med. 2023;12(3):1020. https:\/\/doi.org\/10.3390\/jcm12031020.","journal-title":"J Clin Med"},{"key":"660_CR8","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK; ESC Scientific Document Group. 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023:ehad195. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195.","DOI":"10.1093\/eurheartj\/ehad195"},{"issue":"10367","key":"660_CR9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, Edwards C, Novosadova M, Takagi K, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1.","journal-title":"Lancet"},{"key":"660_CR10","doi-asserted-by":"publisher","unstructured":"Rosano GMC, Moura B, Metra M, B\u00f6hm M, Bauersachs J, Ben Gal T, Adamopoulos S, Abdelhamid M, Bistola V, \u010celutkien\u0117 J, Chioncel O, Farmakis D, Ferrari R, Filippatos G, Hill L, Jankowska EA, Jaarsma T, Jhund P, Lainscak M, Lopatin Y, Lund LH, Milicic D, Mullens W, Pinto F, Ponikowski P, Savarese G, Thum T, Volterrani M, Anker SD, Seferovic PM, Coats AJS. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021;23(6):872-881. https:\/\/doi.org\/10.1002\/ejhf.2206.","DOI":"10.1002\/ejhf.2206"},{"issue":"19","key":"660_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.jacc.2014.02.552","volume":"63","author":"F Fedele","year":"2014","unstructured":"Fedele F, Severino P, Calcagno S, Mancone M. Heart failure: TNM-like classification. J Am Coll Cardiol. 2014;63(19):1959\u201360. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.552.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"660_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ehf2.14594","volume":"11","author":"P Severino","year":"2024","unstructured":"Severino P, Mancone M, D\u2019Amato A, Mariani MV, Prosperi S, Alunni Fegatelli D, Birtolo LI, Angotti D, Milanese A, Cerrato E, Maestrini V, Pizzi C, Fo\u00e0 A, Vestri A, Palazzuoli A, Vizza CD, Casale PN, Mather PJ, Fedele F. Heart failure \u2018the cancer of the heart\u2019: the prognostic role of the HLM score. ESC Heart Fail. 2024;11(1):390\u20139. https:\/\/doi.org\/10.1002\/ehf2.14594.","journal-title":"ESC Heart Fail."},{"issue":"1","key":"660_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10741-019-09828-8","volume":"25","author":"P Severino","year":"2020","unstructured":"Severino P, Maestrini V, Mariani MV, Birtolo LI, Scarpati R, Mancone M, Fedele F. Structural and myocardial dysfunction in heart failure beyond ejection fraction. Heart Fail Rev. 2020;25(1):9\u201317. https:\/\/doi.org\/10.1007\/s10741-019-09828-8.","journal-title":"Heart Fail Rev"},{"issue":"6","key":"660_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ejhf.2149","volume":"23","author":"M Packer","year":"2021","unstructured":"Packer M, McMurray JJV. Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction. Eur J Heart Fail. 2021;23(6):882\u201394. https:\/\/doi.org\/10.1002\/ejhf.2149.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"660_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","volume":"143","author":"JJV McMurray","year":"2021","unstructured":"McMurray JJV, Packer M. How should we sequence the treatments for heart failure and a reduced ejection fraction?: a redefinition of evidence-based medicine. Circulation. 2021;143(9):875\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052926.","journal-title":"Circulation"},{"issue":"4","key":"660_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.cjca.2020.12.028","volume":"37","author":"RJH Miller","year":"2021","unstructured":"Miller RJH, Howlett JG, Fine NM. A novel approach to medical management of heart failure with reduced ejection fraction. Can J Cardiol. 2021;37(4):632\u201343. https:\/\/doi.org\/10.1016\/j.cjca.2020.12.028.","journal-title":"Can J Cardiol"},{"issue":"7","key":"660_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamacardio.2021.0496","volume":"6","author":"SJ Greene","year":"2021","unstructured":"Greene SJ, Butler J, Fonarow GC. Simultaneous or rapid sequence initiation of quadruple medical therapy for heart failure-optimizing therapy with the need for speed. JAMA Cardiol. 2021;6(7):743\u20134. https:\/\/doi.org\/10.1001\/jamacardio.2021.0496.","journal-title":"JAMA Cardiol."},{"key":"660_CR18","doi-asserted-by":"publisher","unstructured":"Tomasoni D, Fonarow GC, Adamo M, Anker SD, Butler J, Coats AJS, Filippatos G, Greene SJ, McDonagh TA, Ponikowski P, Rosano G, Seferovic P, Vaduganathan M, Voors AA, Metra M. Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction. Eur J Heart Fail. 2022;24(3):431\u2013441. https:\/\/doi.org\/10.1002\/ejhf.2397. (Epub 2022 Jan 17. Erratum in: Eur J Heart Fail. 2023 Mar;25(3):443).","DOI":"10.1002\/ejhf.2397"},{"issue":"3","key":"660_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10741-021-10170-1","volume":"28","author":"P Severino","year":"2023","unstructured":"Severino P, D\u2019Amato A, Prosperi S, Costi B, Angotti D, Birtolo LI, Chimenti C, Lavalle C, Maestrini V, Mancone M, Fedele F. Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient. Heart Fail Rev. 2023;28(3):709\u201321. https:\/\/doi.org\/10.1007\/s10741-021-10170-1.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"660_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031.Erratum.In:JAmCollCardiol.2020Sep22;76(12):1505","volume":"75","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Braunwald E. Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(4):422\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.031.Erratum.In:JAmCollCardiol.2020Sep22;76(12):1505.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"660_CR21","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1002\/ehf2.13646","volume":"8","author":"A Abdin","year":"2021","unstructured":"Abdin A, Anker SD, Butler J, Coats AJS, Kindermann I, Lainscak M, Lund LH, Metra M, Mullens W, Rosano G, Slawik J, Wintrich J, B\u00f6hm M. \u2018Time is prognosis\u2019 in heart failure: time-to-treatment initiation as a modifiable risk factor. ESC Heart Fail. 2021;8(6):4444\u201353. https:\/\/doi.org\/10.1002\/ehf2.13646.","journal-title":"ESC Heart Fail."},{"issue":"1","key":"660_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","volume":"11","author":"G Savarese","year":"2023","unstructured":"Savarese G, Kishi T, Vardeny O, Adamsson Eryd S, Bodeg\u00e5rd J, Lund LH, Thuresson M, Bozkurt B. Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF). JACC Heart Fail. 2023;11(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jchf.2022.08.009.","journal-title":"JACC Heart Fail."},{"issue":"10","key":"660_CR23","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/jcm11102790","volume":"11","author":"P Severino","year":"2022","unstructured":"Severino P, D\u2019Amato A, Prosperi S, Magnocavallo M, Maraone A, Notari C, Papisca I, Mancone M, Fedele F. Clinical support through telemedicine in heart failure outpatients during the COVID-19 pandemic period: results of a 12-months follow up. J Clin Med. 2022;11(10):2790. https:\/\/doi.org\/10.3390\/jcm11102790.","journal-title":"J Clin Med"},{"issue":"1","key":"660_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jchf.2019.08.003","volume":"8","author":"NY Tan","year":"2020","unstructured":"Tan NY, Sangaralingham LR, Sangaralingham SJ, Yao X, Shah ND, Dunlay SM. Comparative effectiveness of sacubitril-valsartan versus ACE\/ARB therapy in heart failure with reduced ejection fraction. JACC Heart Fail. 2020;8(1):43\u201354. https:\/\/doi.org\/10.1016\/j.jchf.2019.08.003.","journal-title":"JACC Heart Fail."},{"issue":"14","key":"660_CR25","doi-asserted-by":"publisher","first-page":"1237210","DOI":"10.3389\/fphar.2023.1237210","volume":"4","author":"J Gao","year":"2023","unstructured":"Gao J, Zhang X, Xu M, Deng S, Chen X. The efficacy and safety of sacubitril\/valsartan compared with ACEI\/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2023;4(14):1237210. https:\/\/doi.org\/10.3389\/fphar.2023.1237210.","journal-title":"Front Pharmacol"},{"issue":"8","key":"660_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1177\/10600280221140575","volume":"57","author":"HR Yang","year":"2023","unstructured":"Yang HR, Xu XD, Shaikh AS, Zhou BT. Efficacy and safety of sacubitril\/valsartan compared with ACEI\/ARB on health-related quality of life in heart failure patients: a meta-analysis. Ann Pharmacother. 2023;57(8):907\u201317. https:\/\/doi.org\/10.1177\/10600280221140575.","journal-title":"Ann Pharmacother"},{"key":"660_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-023-00624-y","author":"P Severino","year":"2023","unstructured":"Severino P, Prosperi S, D\u2019Amato A, Cesti\u00e8 C, Myftari V, Maestrini V, Birtolo LI, Filomena D, Mariani MV, Lavalle C, Badagliacca R, Mancone M, Fedele F, Vizza CD. Telemedicine: an effective and low-cost lesson from the COVID-19 pandemic for the management of heart failure patients. Curr Heart Fail Rep. 2023. https:\/\/doi.org\/10.1007\/s11897-023-00624-y.","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"660_CR28","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/ijms25031574","volume":"25","author":"A D'Amato","year":"2024","unstructured":"D\u2019Amato A, Prosperi S, Severino P, Myftari V, Labbro Francia A, Cesti\u00e8 C, Pierucci N, Marek-Iannucci S, Mariani MV, German\u00f2 R, Fanisio F, Lavalle C, Maestrini V, Badagliacca R, Mancone M, Fedele F, Vizza CD. Current approaches to worsening heart failure: pathophysiological and molecular insights. Int J Mol Sci. 2024;25(3):1574. https:\/\/doi.org\/10.3390\/ijms25031574.","journal-title":"Int J Mol Sci"},{"key":"660_CR29","doi-asserted-by":"publisher","unstructured":"Girerd N, Von Hunolstein JJ, Pellicori P, Bay\u00e9s-Gen\u00eds A, Jaarsma T, Lund LH, Bilbault P, Boivin JM, Chouihed T, Costa J, Eicher JC, Fall E, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Zannad N, Rossignol P, Seronde MF; EF-HF Group. Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Fail. 2022;9(4):2063-2069. https:\/\/doi.org\/10.1002\/ehf2.13929.","DOI":"10.1002\/ehf2.13929"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00660-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T16:09:54Z","timestamp":1724515794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00660-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,23]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00660-6","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,23]]},"assertion":[{"value":"2 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Paolo Severino, Andrea D\u2019Amato, Silvia Prosperi, Marco Valerio Mariani, Vincenzo Myftari, Aurora Labbro Francia, Claudia Cesti\u00e8, Elisa Tomarelli, Giovanna Manzi, Lucia Ilaria Birtolo, Stefanie Marek-Iannucci, Viviana Maestrini, Massimo Mancone, Roberto Badagliacca, Francesco Fedele, and Carmine Dario Vizza declare no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the authors participated in the study and made significant intellectual contributions to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The manuscript is not currently under consideration elsewhere, and the work reported will not be submitted for publication elsewhere until a final decision has been made as to its acceptability by the Journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}